Molecular epidemiological study of pyrazinamide-resistance in clinical isolates of mycobacterium tuberculosis from South India
- PMID: 20717529
- PMCID: PMC2920559
- DOI: 10.3390/ijms11072670
Molecular epidemiological study of pyrazinamide-resistance in clinical isolates of mycobacterium tuberculosis from South India
Abstract
Pyrazinamide (PZA) has been in use for almost 50 years as a first-line drug for short-course chemotherapy against Mycobacterium tuberculosis. In this study, PCR mediated automated DNA sequencing is used to check the prevalence of PZA resistance among treatment failure cases of pulmonary tuberculosis. Out of 50 clinical isolates examined, 39 had mutations in the pncA gene that encodes Pyrazinamidase, an enzyme required to activate PZA. Of these, 31 (79.5%) were localized to three regions of pncA. We found two isolates with hitherto unreported mutation at amino acid 26 (Ala-->Gly) of pncA.
Keywords: PZA resistance; South-India; mycobacterium tuberculosis; pncA mutation; pulmonary tuberculosis.
Figures



Similar articles
-
Pyrazinamide resistance and mutations in pncA among isolates of Mycobacterium tuberculosis from Khyber Pakhtunkhwa, Pakistan.BMC Infect Dis. 2019 Feb 6;19(1):116. doi: 10.1186/s12879-019-3764-2. BMC Infect Dis. 2019. PMID: 30728001 Free PMC article.
-
Characterization of pncA mutations of pyrazinamide-resistant Mycobacterium tuberculosis in Turkey.New Microbiol. 2009 Apr;32(2):153-8. New Microbiol. 2009. PMID: 19579692
-
Correlation between pyrazinamide activity and pncA mutations in Mycobacterium tuberculosis isolates in Taiwan.Antimicrob Agents Chemother. 2003 Nov;47(11):3672-3. doi: 10.1128/AAC.47.11.3672-3673.2003. Antimicrob Agents Chemother. 2003. PMID: 14576145 Free PMC article.
-
Mutations Associated with Pyrazinamide Resistance in Mycobacterium tuberculosis: A Review and Update.Curr Microbiol. 2022 Oct 8;79(11):348. doi: 10.1007/s00284-022-03032-y. Curr Microbiol. 2022. PMID: 36209317 Review.
-
The paradox of pyrazinamide: an update on the molecular mechanisms of pyrazinamide resistance in Mycobacteria.J Commun Dis. 2006 Mar;38(3):288-98. J Commun Dis. 2006. PMID: 17373362 Review.
Cited by
-
Frequency and implications of ofloxacin resistance among previously treated tuberculosis patients.J Epidemiol Glob Health. 2017 Sep;7(3):207-208. doi: 10.1016/j.jegh.2017.05.003. Epub 2017 May 24. J Epidemiol Glob Health. 2017. PMID: 28756831 Free PMC article. No abstract available.
-
Role of pncA and rpsA gene sequencing in detection of pyrazinamide resistance in Mycobacterium tuberculosis isolates from southern China.J Clin Microbiol. 2014 Jan;52(1):291-7. doi: 10.1128/JCM.01903-13. Epub 2013 Oct 16. J Clin Microbiol. 2014. PMID: 24131688 Free PMC article.
-
Impact of rpoB gene mutations and Rifampicin-resistance levels on treatment outcomes in Rifampicin-resistant tuberculosis.BMC Infect Dis. 2025 Feb 27;25(1):284. doi: 10.1186/s12879-025-10655-6. BMC Infect Dis. 2025. PMID: 40016696 Free PMC article.
-
Performance of Wayne assay for detection of pyrazinamide resistance in Mycobacterium tuberculosis: a meta-analysis study.New Microbes New Infect. 2021 May 5;42:100886. doi: 10.1016/j.nmni.2021.100886. eCollection 2021 Jul. New Microbes New Infect. 2021. PMID: 34141437 Free PMC article.
-
Resistance To First-Line Antituberculosis Drugs And Prevalence Of pncA Mutations In Clinical Isolates Of Mycobacterium tuberculosis From Zunyi, Guizhou Province Of China.Infect Drug Resist. 2019 Sep 30;12:3093-3102. doi: 10.2147/IDR.S222943. eCollection 2019. Infect Drug Resist. 2019. PMID: 31686870 Free PMC article.
References
-
- Barco1 P, Cardoso RF, Hirata1 RDC, Leite CQF, Pandolfi JR, Sato DN, Shikama ML, Fiúza de Melo F, Mamizuka1 EM, Campanerut PAZ, Hirata MH. pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis clinical isolates from the southeast region of Brazil. J. Antimicrob. Chemother. 2006;58:930–935. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical